
Novorapid Penfill 100 Iu Inj 3 Ml Cartridge (5 Pcs)
Insulin Aspart (100iu/ml)
Source ID: 243034
₹4685.12
₹3699.37
(Inclusive of all taxes)Batch
-
PKG
5 CARTRIDG
Expiry
-
MRP
₹4685.12
Stock
5
Discount
21.04%
Description
NOVORAPID PENFILL 100 IU INJ 3 ML CARTRIDGE (5 PCS)
NovoRapid Penfill 100 IU is a rapid-acting insulin analog used to manage blood sugar levels in individuals with diabetes mellitus. It is available as a clear, colorless, aqueous solution for injection.
Composition
- Active Ingredient: Each ml contains 100 units of Insulin Aspart (equivalent to 3.5 mg), produced in Saccharomyces cerevisiae by recombinant DNA technology.
- Other Ingredients: Glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide, and water for injections.
Uses
NovoRapid Penfill is prescribed to improve glycemic control in patients with Type 1 and Type 2 diabetes mellitus. It is suitable for adults, adolescents, and children aged 1 year and above. This medication helps to rapidly lower blood glucose levels, particularly after meals, thereby preventing the risk of severe diabetic complications.
Dosage and Administration
- Dosage: The dosage is individualized and determined by a healthcare professional based on the patient's needs and regular blood glucose monitoring.
- Administration: NovoRapid is typically administered by subcutaneous injection (under the skin) immediately before a meal (within 5-10 minutes) or, if necessary, shortly after a meal.
- Injection Sites: Preferred sites include the abdominal wall, thigh, upper arm, deltoid, or gluteal region. It is crucial to rotate injection sites within the same region to reduce the risk of local skin reactions.
- Combination Therapy: NovoRapid Penfill is usually used in combination with intermediate-acting or long-acting insulin preparations.
- Other Uses: It can also be utilized for continuous subcutaneous insulin infusion (CSII) in compatible pump systems and may be administered intravenously under strict medical supervision.
Side Effects
- Very Common: Hypoglycemia (low blood sugar), which can manifest as confusion, headache, hunger, mood changes, palpitations, rapid breathing, cold sweats, and shakiness.
- Common/Uncommon:
- Injection site reactions such as pain, redness, hives, inflammation, bruising, swelling, and itching.
- Lipodystrophy (fat shrinking or thickening under the skin) and cutaneous amyloidosis (lumps under the skin) can occur with repeated injections at the same site.
- Rash, pruritus (itching), weight gain, and oedema (swelling due to fluid retention).
- Temporary vision problems at the start of insulin treatment.
- Hypokalemia (low blood potassium).
Precautions
- Label Check: Always verify the insulin label before each injection to prevent accidental mix-ups with other insulin products.
- Needle Safety: Never reuse or share needles or Penfill cartridges to prevent contamination and the transmission of blood-borne pathogens.
- Injection Site Rotation: Continuously rotate injection sites within the same area to minimize the risk of lipodystrophy and cutaneous amyloidosis.
- Blood Glucose Monitoring: Close monitoring of blood glucose is recommended, particularly when changing injection sites, during illness, increased physical activity, or dietary modifications.
- Special Populations: Use with caution in patients with kidney or liver impairment, thyroid disorders, or those over 65 years of age, as dose adjustments may be necessary.
- Alcohol Consumption: Avoid alcohol, as it can significantly impact blood glucose levels, potentially leading to hypoglycemia or hyperglycemia.
- Concomitant Medications: If used with pioglitazone, patients should be observed for signs and symptoms of heart failure, weight gain, and oedema.
- Pump Failure: Patients using continuous subcutaneous insulin infusion (CSII) systems must always have an alternative insulin delivery method readily available.
Storage
- Unopened Cartridges: Store in a refrigerator at 2°C to 8°C. Do not freeze and keep away from the cooling element.
- In-use or Spare Cartridges: Can be kept at room temperature (below 30°C) for up to 4 weeks. Do not refrigerate or freeze during use.
- Protection: Always keep cartridges in the outer carton to protect them from light and excessive heat.
- Inspection: Do not use the medicine if the solution is not clear and colorless, if it appears damaged, or if it has been frozen.
- Disposal: Discard the Penfill cartridge 4 weeks after first use, even if it still contains some insulin. Always remove and discard the needle after each injection.
- Child Safety: Keep out of the sight and reach of children.
₹4685.12
₹3699.37
(Inclusive of all taxes)Shop by Frequently Purchased Items
Frequently Asked Questions
NOVORAPID PENFILL 100 IU INJ 3 ML CARTRIDGE contains insulin aspart, a rapid-acting insulin analogue used to manage blood sugar levels in people with diabetes mellitus. It is prescribed for both Type 1 and Type 2 diabetes in adults, adolescents, and children aged 1 year and above.
Here are some frequently asked questions about NOVORAPID PENFILL:
What is NOVORAPID PENFILL used for?
NOVORAPID PENFILL is used to treat diabetes mellitus (Type 1 and Type 2) in adults, adolescents, and children aged 1 year and above. It helps to lower high blood sugar levels and prevent complications associated with diabetes.
How does NOVORAPID PENFILL work?
NOVORAPID PENFILL contains insulin aspart, which is a rapid-acting insulin. It works by mimicking the body's natural insulin, increasing the uptake of glucose into muscle and fat cells and inhibiting the liver from producing more glucose, thereby lowering blood sugar levels. It starts to work within 10 to 20 minutes, has a maximum effect between 1 to 3 hours, and its effects can last for up to 5 hours.
What is the usual dosage?
The dosage of NOVORAPID PENFILL is individualized and determined by a doctor based on the patient's specific needs. It is typically used in combination with intermediate-acting or long-acting insulin preparations. It should be injected immediately before a meal, or, if necessary, shortly after starting a meal. It is important to eat a meal or snack containing carbohydrates within 10 minutes of the injection to prevent low blood sugar.
What are the possible side effects?
The most common side effect is low blood sugar levels (hypoglycemia). Symptoms of mild to moderate hypoglycemia can include cold sweats, nervousness, shakiness, rapid heartbeat, headache, hunger, confusion, lightheadedness, weakness, and numbness or tingling of the tongue, lips, or fingers. Other possible side effects at the injection site include pain, redness, hives, bruising, swelling, or itching, which usually disappear within a few weeks. Skin changes like thickening, shrinking, or lumps (lipodystrophy or cutaneous amyloidosis) can also occur at the injection site if rotated insufficiently.
Is it safe during pregnancy or breastfeeding?
NOVORAPID PENFILL can be used during pregnancy, but your insulin dose may need to be adjusted by your doctor during pregnancy and after delivery. Careful control of diabetes, particularly preventing hypoglycemia, is important for the health of the baby. There are no restrictions on using NOVORAPID PENFILL while breastfeeding.
Can it be taken with other medications?
Yes, but some medicines can affect blood sugar levels and may require an adjustment in the insulin dose. Medications that may reduce insulin requirements include other antidiabetic medicines, MAOIs, beta-blockers, ACE inhibitors, salicylates, anabolic steroids, and sulfonamides. Conversely, substances like oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone, and danazol may increase insulin requirements. Beta-blockers can also mask the symptoms of hypoglycemia. It's crucial to inform your doctor, nurse, or pharmacist about all medicines you are taking.
What precautions should be taken?
Always check the label to ensure it's the correct type of insulin and inspect the cartridge for any damage before use. Do not use the medicine if it has been frozen or exposed to excessive heat, or if the solution is not clear and colorless. Rotate injection sites regularly to reduce the risk of skin changes. If you have kidney or liver problems, or are over 65, your doctor may need to adjust your insulin dose. Always carry a spare Penfill cartridge and some sugary food or fruit juice in case of low blood sugar. Alcohol consumption can affect blood sugar levels and should be discussed with your doctor.
What happens if a dose is missed?
If you miss a dose, test your blood sugar level as soon as possible. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not use a double dose to make up for a missed one. Your blood sugar levels may become high (hyperglycemia) if you miss doses.
How should it be stored?
Unopened NOVORAPID PENFILL cartridges should be stored in a refrigerator between 2°C and 8°C, away from the freezer element, and not frozen. Cartridges currently in use or carried as a spare can be kept at room temperature (not above 30°C) for up to 4 weeks. Protect the medicine from excessive heat, light, and do not freeze it. Discard the Penfill cartridge after 4 weeks, even if there is still some insulin left. Keep it out of the reach of children.










































